Literature DB >> 29929445

Hyperandrogenism Induces Histo-Architectural Changes in the Rat Uterus.

Gisela Soledad Bracho1, Gabriela Anahí Altamirano1,2, Laura Kass1,2, Enrique Hugo Luque1,3, Verónica Lis Bosquiazzo1,4.   

Abstract

The effects of androgens on the uterus have been poorly studied and they need to be clarified to understand why androgen excess, such as observed in women with polycystic ovary syndrome (PCOS), is a risk factor for the development of endometrial hyperplasia, cancer, and infertility. Thus, uterine histomorphology in a PCOS experimental model was evaluated. Beginning at weaning, female rats were injected daily with dehydroepiandrosterone (DHEA, 6 mg/100 g body weight) or vehicle (sesame oil) for 20 consecutive days. On postnatal day 41 (PND41), DHEA-treated animals showed high serum testosterone levels. In addition, uterine histological analysis showed a significant increase in luminal epithelial height and glandular density without changes in cell proliferation. The thickness of the subepithelial stroma and myometrium also increased in these animals. The effect of DHEA on uterine thickness was accompanied by a significant reduction in cell density in both tissue compartments (subepithelial stroma and myometrium). Cell proliferation was not altered in the myometrium, whereas a decrease in the proliferative activity was seen at PND41 in the subepithelial stroma of DHEA animals. The analysis of the extracellular space showed that the changes in the thickness of the subepithelial stroma and myometrium were related to an increase in the organization of collagen fibers and water imbibition. The latter was associated with higher aquaporin 3 and 8 expression. This study provides evidence to further the understanding of PCOS-associated hyperandrogenism effects on uterine architecture. This could have implications for the regulation of uterine function and the development of uterine lesions.

Entities:  

Keywords:  aquaporin; cell proliferation; collagen; dehydroepiandrosterone; uterus

Year:  2018        PMID: 29929445     DOI: 10.1177/1933719118783881

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  6 in total

1.  Structural and functional changes in rat uterus induced by neonatal androgenization.

Authors:  Rebeca Chávez-Genaro; Agustina Toledo; Karina Hernández; Gabriel Anesetti
Journal:  J Mol Histol       Date:  2022-10-06       Impact factor: 3.156

2.  Effects of N-acetylcysteine and metformin treatment on the stereopathological characteristics of uterus and ovary.

Authors:  Bahare Rafiee; Saied Karbalay-Doust; Seyed Mohammad Bagher Tabei; Negar Azarpira; Sanaz Alaee; Parvin Lohrasbi; Soghra Bahmanpour
Journal:  Eur J Transl Myol       Date:  2022-05-09

3.  Polycystic Ovary Syndrome and the Forgotten Uterus.

Authors:  Pardis Hosseinzadeh; Maya Barsky; William E Gibbons; Chellakkan S Blesson
Journal:  F S Rev       Date:  2020-12-13

4.  Ficus deltoidea ameliorates biochemical, hormonal, and histomorphometric changes in letrozole-induced polycystic ovarian syndrome rats.

Authors:  Muhammad Aliff Haslan; Nurdiana Samsulrizal; Nooraain Hashim; Noor Syaffinaz Noor Mohamad Zin; Farshad H Shirazi; Yong Meng Goh
Journal:  BMC Complement Med Ther       Date:  2021-11-29

5.  Exploration of molecular features of PCOS with different androgen levels and immune-related prognostic biomarkers associated with implantation failure.

Authors:  Qinyu Gao; Cong Ma; Shuyu Meng; Guanxiong Wang; Qiong Xing; Yuping Xu; Xiaojin He; Tianjuan Wang; Yunxia Cao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-19       Impact factor: 6.055

6.  Therapeutic effects of aqueous extract of bioactive active component of Ageratum conyzoides on the ovarian-uterine and hypophysis-gonadal axis in rat with polycystic ovary syndrome: Histomorphometric evaluation and biochemical assessment.

Authors:  Sunday Aderemi Adelakun; Victor Okoliko Ukwenya; Akwu Bala Peter; Adewale Jacob Siyanbade; Comfort Oluwakorede Akinwumiju
Journal:  Metabol Open       Date:  2022-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.